Source: ClinicalTrials.gov
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
View on ClinicalTrials.govCitation record
- Study start
- 2024-11-01
- NCT number
- NCT06662383
- Phase
- Phase3
- Overall status
- Active Not Recruiting
- Study type
- Interventional
- Lead sponsor
- Eli Lilly and Company
- Enrollment
- 800 participants
- Conditions
- Obesity
- Interventions
- Retatrutide (Drug) · Tirzepatide (Drug)
- Last updated at source
- 20 Jul 2026
- Original source
- https://clinicaltrials.gov/study/NCT06662383
This page reproduces citation metadata only. Inclusion in the Avion Science research library does not imply endorsement and does not establish the safety, efficacy or intended use of any Avion Science compound. Refer to the original record for complete study information.